ApeX Protocol vs Enzyme — how do they compare? ApeX Protocol trades at Rp3,670 (market cap Rp538,42M, Rp17,53M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: ApeX Protocol is far larger — about 4× Enzyme's market cap, and ApeX Protocol's supply is capped (146,2M / 500M APEX (30%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold ApeX Protocol for 20 Days and Enzyme for 29 Days on average.
| APEX | MLN | |
|---|---|---|
Market Cap | Rp538,42M | Rp134,13M |
Volume (24h) | Rp17,53M | Rp104,56M |
Circulating Supply | 146,2M / 500M APEX (30%) | 3,3M MLN |
Typical Hold Time | 20 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
ApeX Protocol (APEX) is trading at Rp3,742 with a market cap of Rp547.43 million, showing a bearish technical signal overall. The asset is near support at S1 (Rp3,648) with RSI_6 at 27.48 indicating potential oversold conditions. Only 30% of the max supply (500 million APEX) is in circulation, with an average hold time of 20 days. Recent news from GlobeNewsWire (2026-06-18) discusses survey results but is unrelated to the token's protocol or ecosystem developments.
Overall outlook remains cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include oversold RSI levels for potential short-term rebounds, while major risks involve low liquidity, high volatility, and lack of recent protocol updates. Investors should monitor support levels closely for any breakdown or reversal signals.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
ApeX Protocol is a decentralized, non-custodial, permissionless, and censorship-resistant perpetual derivatives protocol. It facilitates the creation of perpetual swap markets for any token pairs. Users can engage in crypto derivatives trading on the Ethereum blockchain without intermediaries, while retaining complete control over their private keys.
Read more on APEX →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →